Candid
PrivateLast Round
Series B
Apr 16, 2019
Total Funding Raised
$80.4M
Company Overview
Candid (Therapeutic Devices) is a dental technology company that provides a digital platform for custom clear aligners made from Bisphenol A-free plastic, designed to offer a comfortable and effective alternative to traditional braces for teeth straightening.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Telemedicine, Vertical SaaS
Business Model
B2B2C
Customer Profile
Hardware Sales, Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Candid Comps
Public and private peers based on sector, stage, and business model.
Candid Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Apr 16, 2019 | ||||
| Series A | Nov 22, 2017 |
Key People
Founding team and executive leadership
Candid Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Arena Ventures | Series A, Seed |
| Cyrus Investments | Series B |
| Riverpark Funds | Series B |
| Greycroft | Series B, Series A |
| Mousse Partners | Series B |
| Bessemer Venture Partners | Series B, Series A |
| blisce/ | Series B |
Candid Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Candid's valuation, stock price, and market status.
